Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 395,800 | 369,300 | 521,400 | 488,100 | 410,377 |
| Marketable Securities | 1,022,800 | 1,004,500 | 1,139,000 | 1,176,400 | 1,217,641 |
| Receivables | 464,700 | 469,900 | 424,700 | 452,500 | 461,940 |
| Inventories | 783,200 | 798,800 | 790,100 | 760,000 | 804,276 |
| Other current assets | 23,500 | 19,000 | 36,000 | 30,700 | 28,158 |
| TOTAL | $2,842,000 | $2,811,100 | $3,036,600 | $3,030,300 | $3,055,620 |
| Non-Current Assets | |||||
| PPE Net | 540,200 | 549,700 | 528,500 | 528,100 | 545,304 |
| Investments And Advances | 5,057,800 | 5,576,500 | 4,994,200 | 4,839,200 | 6,002,635 |
| Intangibles | 967,100 | 978,500 | 710,700 | 704,100 | 722,425 |
| Other Non-Current Assets | 289,300 | 298,300 | 256,901 | 262,400 | 277,489 |
| TOTAL | $6,854,400 | $7,403,000 | $6,490,301 | $6,333,800 | $7,547,853 |
| Total Assets | $9,696,400 | $10,214,100 | $9,526,900 | $9,364,100 | $10,603,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,300 | 1,300 | 1,200 | 1,200 | 1,262 |
| Accounts payable and accrued liabilities | 128,800 | 139,300 | 137,900 | 122,300 | 122,185 |
| Accrued Expenses | 182,800 | 157,800 | 157,400 | 124,200 | 146,024 |
| Other current liabilities | 127,800 | 175,000 | 131,700 | 147,200 | 142,013 |
| TOTAL | $522,300 | $548,900 | $506,600 | $467,800 | $497,943 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,201,400 | 1,201,100 | 1,200,700 | 1,200,400 | 1,200,062 |
| Other Non-Current Liabilities | 363,300 | 374,400 | 299,400 | 308,600 | 341,550 |
| TOTAL | $2,437,300 | $2,536,500 | $2,340,900 | $2,327,000 | $2,617,670 |
| Total Liabilities | $2,959,600 | $3,085,400 | $2,847,500 | $2,794,800 | $3,115,613 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,975 | 27,062 | 27,213 | 28,011 | 27,997 |
| Common Shares | N/A | N/A | N/A | N/A | 3 |
| Retained earnings | 7,456,300 | 7,798,200 | 7,480,400 | 7,416,400 | 8,132,231 |
| Other shareholders' equity | -166,400 | -154,100 | -409,700 | -538,300 | -315,704 |
| TOTAL | $6,736,800 | $7,128,700 | $6,679,400 | $6,569,300 | $7,487,859 |
| Total Liabilities And Equity | $9,696,400 | $10,214,100 | $9,526,900 | $9,364,100 | $10,603,472 |